BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20852007)

  • 1. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men.
    Steinbrecher A; Méplan C; Hesketh J; Schomburg L; Endermann T; Jansen E; Akesson B; Rohrmann S; Linseisen J
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2958-68. PubMed ID: 20852007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
    Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
    Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of selenium and selenoprotein gene variants on colorectal cancer risk.
    Méplan C; Hesketh J
    Mutagenesis; 2012 Mar; 27(2):177-86. PubMed ID: 22294765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in selenoprotein genes increase risk of colorectal cancer.
    Méplan C; Hughes DJ; Pardini B; Naccarati A; Soucek P; Vodickova L; Hlavatá I; Vrána D; Vodicka P; Hesketh JE
    Carcinogenesis; 2010 Jun; 31(6):1074-9. PubMed ID: 20378690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.
    Penney KL; Schumacher FR; Li H; Kraft P; Morris JS; Kurth T; Mucci LA; Hunter DJ; Kantoff PW; Stampfer MJ; Ma J
    Cancer Prev Res (Phila); 2010 May; 3(5):604-10. PubMed ID: 20424130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer.
    Ekoue DN; Ansong E; Liu L; Macias V; Deaton R; Lacher C; Picklo M; Nonn L; Gann PH; Kajdacsy-Balla A; Prins GS; Freeman VL; Diamond AM
    Prostate; 2018 Mar; 78(4):279-288. PubMed ID: 29314169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer.
    Kote-Jarai Z; Durocher F; Edwards SM; Hamoudi R; Jackson RA; Ardern-Jones A; Murkin A; Dearnaley DP; Kirby R; Houlston R; Easton DF; Eeles R;
    Prostate Cancer Prostatic Dis; 2002; 5(3):189-92. PubMed ID: 12496980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium and cancer: a story that should not be forgotten-insights from genomics.
    Méplan C; Hesketh J
    Cancer Treat Res; 2014; 159():145-66. PubMed ID: 24114479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressed serum selenoprotein P: possible new predicator of increased risk for cerebrovascular events.
    Koyama H; Abdulah R; Ohkubo T; Imai Y; Satoh H; Nagai K
    Nutr Res; 2009 Feb; 29(2):94-9. PubMed ID: 19285599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.
    Méplan C; Rohrmann S; Steinbrecher A; Schomburg L; Jansen E; Linseisen J; Hesketh J
    PLoS One; 2012; 7(11):e48709. PubMed ID: 23133653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum selenium and subsequent risk of prostate cancer.
    Nomura AM; Lee J; Stemmermann GN; Combs GF
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):883-7. PubMed ID: 11008904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selenium status, dietary glucosinolate intake and serum glutathione S-transferase α activity on the risk of benign prostatic hyperplasia.
    Eichholzer M; Steinbrecher A; Kaaks R; Teucher B; Linseisen J; Rohrmann S
    BJU Int; 2012 Dec; 110(11 Pt C):E879-85. PubMed ID: 22882569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
    Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
    Gerstenberger JP; Bauer SR; Van Blarigan EL; Sosa E; Song X; Witte JS; Carroll PR; Chan JM
    Prostate; 2015 Jan; 75(1):60-9. PubMed ID: 25284284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk.
    Goodman GE; Schaffer S; Bankson DD; Hughes MP; Omenn GS;
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1069-76. PubMed ID: 11588133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.
    Paz-y-Miño C; Witte T; Robles P; Llumipanta W; Díaz M; Arévalo M
    Cancer Genet Cytogenet; 2009 Mar; 189(2):71-6. PubMed ID: 19215786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
    Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.